Negative
●
24/7 Wall Street
●
6 months ago
Colgate-Palmolive (NYSE:CL) lost a key Wall Street backer on Tuesday as TD Cowen analyst Robert Moskow downgraded the stock from Buy to Hold and cut his price target to $85 from $96, citing surging oil-based input costs tied to the Iran War.